Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Short-term marketable securities
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use asset
Long-term marketable securities
Other assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Operating lease liability, current portion
Total current liabilities
Operating lease liability, net of current portion
Restricted stock liability, net of current portion
Total liabilities
Redeemable convertible preferred stock (Series A and B), $0.0001 par value; 0 and 22,136,987 shares authorized as of December 31, 2021 and December 31, 2020, respectively; 0 and 16,734,179 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively; preference in liquidation of $0 as of December 31, 2021
SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK
SERIES B REDEEMABLE CONVERTIBLE PREFERRED STOCK
Total redeemable convertible preferred stock (Series A and B), $0.0001 par value; 0 and 22,136,987 shares authorized as of December 31, 2021 and December 31, 2020, respectively; 0 and 16,734,179 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively; preference in liquidation of $0 as of December 31, 2021
Stockholders’ equity:
Preferred stock, $0.0001 par value; 50,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 0 shares issued and outstanding as of September 30, 2023 and December 31, 2022
Common stock, $0.0001 par value; 500,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 43,605,080 and 38,734,446 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support